186 related articles for article (PubMed ID: 19842097)
21. A modified pseudolikelihood approach for analysis of longitudinal data.
Wang YG; Zhao Y
Biometrics; 2007 Sep; 63(3):681-9. PubMed ID: 17825002
[TBL] [Abstract][Full Text] [Related]
22. Commentary: multilevel endpoints and the problems of theoretical aggregation and overlapping.
Adamiak GT
J Clin Epidemiol; 2008 Feb; 61(2):198-9; author reply 199-201. PubMed ID: 18177794
[No Abstract] [Full Text] [Related]
23. Preface.
Hougaard P
Stat Med; 2010 Mar; 29(7-8):711. PubMed ID: 20213701
[No Abstract] [Full Text] [Related]
24. Analyzing the content of outcome measures in clinical trials on irritable bowel syndrome using the international classification of functioning, disability and health as a reference.
Schönrich S; Brockow T; Franke T; Dembski R; Resch KL; Cieza A
Rehabilitation (Stuttg); 2006 Jun; 45(3):172-80. PubMed ID: 16755436
[TBL] [Abstract][Full Text] [Related]
25. Understanding clinical trial outcomes: design, analysis, and interpretation.
Jacobe HT; Leitenberger JJ; Bergstresser PR
Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
[TBL] [Abstract][Full Text] [Related]
26. How to design a clinical trial.
Curtis BM; Barrett BJ; Parfrey PS
Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789
[No Abstract] [Full Text] [Related]
27. Missing data and convenient assumptions.
Normand SL
Circ Cardiovasc Qual Outcomes; 2010 Jan; 3(1):2-3. PubMed ID: 20123663
[No Abstract] [Full Text] [Related]
28. [The use of state of the art statistical methodology in biomedical research: the example of methodology for interim analyses in clinical trials].
Muñoz SR; Bangdiwala SI
Rev Med Chil; 2001 Sep; 129(9):983-8. PubMed ID: 11725478
[TBL] [Abstract][Full Text] [Related]
29. Outcome reporting bias in clinical trials.
Esposito E; Cipriani A; Barbui C
Epidemiol Psichiatr Soc; 2009; 18(1):17-8. PubMed ID: 19378694
[No Abstract] [Full Text] [Related]
30. A hundred (and one) graphs tell only part of the story.
Silbergleit R
Ann Emerg Med; 2009 Sep; 54(3):342-3. PubMed ID: 19695418
[No Abstract] [Full Text] [Related]
31. [Regression to the mean].
Zwingmann C; Wirtz M
Rehabilitation (Stuttg); 2005 Aug; 44(4):244-51. PubMed ID: 16059843
[TBL] [Abstract][Full Text] [Related]
32. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues.
Sankoh AJ; D'Agostino RB; Huque MF
Stat Med; 2003 Oct; 22(20):3133-50. PubMed ID: 14518019
[TBL] [Abstract][Full Text] [Related]
33. The statistical comparison of clinical trials.
Schooler NR
J Clin Psychiatry; 2001; 62 Suppl 9():35-7; discussion 38-9. PubMed ID: 11379830
[TBL] [Abstract][Full Text] [Related]
34. [Interpretation of clinical studies].
Jahrmäker H
Med Klin (Munich); 1995 Jan; 90(1):45-52. PubMed ID: 7885305
[No Abstract] [Full Text] [Related]
35. 31st Annual Conference of the International Society for Clinical Biostatistics. Preface.
Lesaffre E; Gerds T
Stat Med; 2012 May; 31(11-12):1001. PubMed ID: 22585410
[No Abstract] [Full Text] [Related]
36. The clinical significance of new therapies for the management of periodontal disease.
Van Dyke TE
J Int Acad Periodontol; 2005 Oct; 7(4 Suppl):191-6. PubMed ID: 16248275
[TBL] [Abstract][Full Text] [Related]
37. What is next in ALS clinical trials?
Sorenson EJ
Neurology; 2007 Aug; 69(8):719-20. PubMed ID: 17709702
[No Abstract] [Full Text] [Related]
38. Some alternative perspectives concerning medical technology assessment.
Diamond GA
J Invasive Cardiol; 1992; 4(1):39-44. PubMed ID: 10149903
[No Abstract] [Full Text] [Related]
39. Special issue of statistical genetics and genomics in clinical trials: guest editor's note.
Wu R; Lin M
J Biopharm Stat; 2010 Mar; 20(2):191-2. PubMed ID: 20309753
[No Abstract] [Full Text] [Related]
40. [Evaluation of treatment effects in quasi-experimental studies].
Kirchmann H; Steyer R
Psychother Psychosom Med Psychol; 2012; 62(3-4):149-51. PubMed ID: 22473432
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
